Skip to main content
Iris Isufi, MD, Oncology, New Haven, CT

IrisIsufiMD

Oncology New Haven, CT

Assistant Professor, Comprehensive Cancer Center, Yale University School of Medicine

Dr. Isufi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Isufi's full profile

Already have an account?

  • Office

    20 York St
    # Yale
    New Haven, CT 06510
    Phone+1 646-943-4060
    Fax+1 203-200-2026

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2008 - 2011
  • Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)
    Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2004 - 2007
  • Stony Brook University Health Sciences Center School of Medicine
    Stony Brook University Health Sciences Center School of MedicineClass of 2004

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 2011 - 2025
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • A Phase Ia/Ib Study Exploring the Synthetic Lethality of the Orally Administered Novel BTK Inhibitor, Dtrmwxhs-12 (DTRM-12), in Combination with Everolimus and Pomalid...
    Iris Isufi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • A Phase 1 Study of ACTR087 in Combination with Rituximab, in Subjects with Relapsed or Refractory CD20-Positive B-Cell Lymphoma
    Iris Isufi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Peripheral Blood Involvement By Flow Cytometry As a Prognostic Factor in Aggressive T Cell Lymphomas Following Autologous Stem Cell Transplantation
    Iris Isufi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Press Mentions

  • Smilow Cancer Hospital Cellular Therapies Program
    Smilow Cancer Hospital Cellular Therapies ProgramJuly 30th, 2024
  • Oncternal Therapeutics : Lee 2022 ASCO Poster Zilovertamab + Ibrutinib for MCL and CLL
    Oncternal Therapeutics : Lee 2022 ASCO Poster Zilovertamab + Ibrutinib for MCL and CLLJune 7th, 2022

Professional Memberships